Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays

Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific MAS Omni Infectious Disease quality control sets for monitoring serological assays for analytes such as HIV 1&2, Hepatitis B & C virus, Syphilis and HTLV I/II.

Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays

Serology testing for infectious diseases continues to be on the rise and newer instrument platforms are offering serology markers with improved sensitivity than previously available. In addition, there is continued progression with infectious disease screening protocols requiring serology testing for diagnosis, monitoring and treatment of infectious agents.

The Thermo Scientific MAS Omni Infectious positive and negative quality controls are  third-party, independent external controls used to assess the performance of serological assays for infectious diseases. Our new control set supports assays for HIV, Hepatitis C, Hepatitis B, HTLV and Syphilis. As with all Thermo Scientific MAS Quality Controls users can efficiently monitor assay performance, streamline operations and potentially reduce your spending without sacrificing quality or throughput.

We are expanding our quality control offering into a space which continues to increase each year as new pharma drugs are developed and enabling better identification and treatment for infectious diseases. Our team is committed to providing innovative solutions to support our customers productivity. The Thermo Scientific MAS Omni Infectious Controls are the first in a line of products we are continuing to develop to support the monitoring of  in vitro diagnostic tests."

Fernando Beils, Vice president and general manager, Thermo Fisher's niche diagnostics business

The Thermo Scientific MAS Omni Infectious Controls are available in the U.S. and Japan as IVD products and are intended for clinical use.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2020, July 03). Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays. News-Medical. Retrieved on August 14, 2020 from https://www.news-medical.net/news/20200703/Thermo-Scientific-MAS-Omni-Infectious-Controls-launched-to-assess-the-performance-of-serological-assays.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays". News-Medical. 14 August 2020. <https://www.news-medical.net/news/20200703/Thermo-Scientific-MAS-Omni-Infectious-Controls-launched-to-assess-the-performance-of-serological-assays.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays". News-Medical. https://www.news-medical.net/news/20200703/Thermo-Scientific-MAS-Omni-Infectious-Controls-launched-to-assess-the-performance-of-serological-assays.aspx. (accessed August 14, 2020).

  • Harvard

    Thermo Fisher Scientific Inc.. 2020. Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays. News-Medical, viewed 14 August 2020, https://www.news-medical.net/news/20200703/Thermo-Scientific-MAS-Omni-Infectious-Controls-launched-to-assess-the-performance-of-serological-assays.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Thermo Fisher Scientific launches industry-leading, cGMP-compatible CTS Series Laboratory Equipment